$CVV
CVD EQUIPMENT CORP Stock $cvv

$cvv Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223041031 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$4.111M	$6.234M
YoY Change	-43.17%	-23.22%
Cost Of Revenue	$4.459M	$4.636M
YoY Change	-14.8%	-18.65%
Gross Profit	-$348.0K	$1.598M
YoY Change	-117.4%	-33.96%
Gross Profit Margin	-8.47%	25.63%
Selling, General & Admin	$1.392M	$1.884M
YoY Change	-18.72%	5.87%
% of Gross Profit		117.9%
Research & Development	$731.0K	$704.0K
YoY Change	43.73%	35.91%
% of Gross Profit		44.06%
Depreciation & Amortization	$242.0K	$160.0K
YoY Change	-26.47%	18.0%
% of Gross Profit		10.01%
Operating Expenses	$2.123M	$2.588M
YoY Change	-4.42%	12.64%
Operating Profit	-$2.471M	-$990.0K
YoY Change	1017.29%	-911.48%
Interest Expense	$172.0K	$6.000K
YoY Change	-28.49%	3673.58%
% of Operating Profit
Other Income/Expense, Net	$0.00	$237.0K
YoY Change	-100.0%	4259.02%
Pretax Income	-$2.299M	-$753.0K
YoY Change	-248.1%	-1276.56%
Income Tax	-$25.00K
% Of Pretax Income
Net Earnings	-$2.274M	-$753.0K
YoY Change	-246.79%	-1285.12%
Net Earnings / Revenue	-55.32%	-12.08%
Basic Earnings Per Share		-$0.11
Diluted Earnings Per Share	-$0.33	-$0.11
COMMON SHARES
Basic Shares Outstanding	6.825M shares	6.814M
Diluted Shares Outstanding		6.789M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.03M	$14.29M
YoY Change	-2.37%	20.33%
Cash & Equivalents	$14.00M	$14.30M
Short-Term Investments
Other Short-Term Assets	$852.0K	$848.0K
YoY Change	6.9%	51.42%
Inventory	$4.454M	$4.290M
Prepaid Expenses
Receivables	$1.906M	$2.585M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$22.84M	$24.90M
YoY Change	-3.45%	21.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.17M	$12.21M
YoY Change	-3.41%	-4.73%
Goodwill
YoY Change
Intangibles	$9.000K	$107.0K
YoY Change	-92.44%	-47.93%
Long-Term Investments
YoY Change
Other Assets	$9.000K	$10.00K
YoY Change	-10.0%	4.49%
Total Long-Term Assets	$12.18M	$12.32M
YoY Change	-14.52%	-5.41%
TOTAL ASSETS
Total Short-Term Assets	$22.84M	$24.90M
Total Long-Term Assets	$12.18M	$12.32M
Total Assets	$35.03M	$37.23M
YoY Change	-7.62%	10.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.203M	$1.477M
YoY Change	-17.26%	-3.08%
Accrued Expenses	$1.765M	$1.711M
YoY Change	-31.88%	-30.04%
Deferred Revenue	$4.908M	$4.858M
YoY Change	21.43%	228.71%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$81.00K	$80.00K
YoY Change	5.19%	4.74%
Total Short-Term Liabilities	$8.554M	$8.723M
YoY Change	4.78%	57.91%
LONG-TERM LIABILITIES
Long-Term Debt	$268.0K	$288.0K
YoY Change	-23.21%	-19.01%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$268.0K	$288.0K
YoY Change	-23.21%	-19.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.554M	$8.723M
Total Long-Term Liabilities	$268.0K	$288.0K
Total Liabilities	$8.822M	$9.011M
YoY Change	3.63%	53.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.560M	-$286.0K
YoY Change	-258.02%	-506.35%
Common Stock	$28.76M	$28.50M
YoY Change	3.54%	3.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$26.20M	$28.22M
YoY Change
Total Liabilities & Shareholders Equity	$35.03M	$37.23M
YoY Change	-7.62%	10.79%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$2.274M	-$753.0K
YoY Change	-246.79%	-1285.12%
Depreciation, Depletion And Amortization	$242.0K	$160.0K
YoY Change	-26.47%	18.0%
Cash From Operating Activities	-$126.0K	$750.0K
YoY Change	-104.99%	-849.63%
INVESTING ACTIVITIES
Capital Expenditures	$110.0K	$80.00K
YoY Change	305.46%	-143.69%
Acquisitions
YoY Change
Other Investing Activities	-$3.000K	$600.0K
YoY Change
Cash From Investing Activities	-$113.0K	$520.0K
YoY Change	316.51%	-384.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-21.00K	-20.00K
YoY Change	223.57%
NET CHANGE
Cash From Operating Activities	-126.0K	750.0K
Cash From Investing Activities	-113.0K	520.0K
Cash From Financing Activities	-21.00K	-20.00K
Net Change In Cash	-260.0K	1.250M
YoY Change	-110.44%	-541.48%
FREE CASH FLOW
Cash From Operating Activities	-$126.0K	$750.0K
Capital Expenditures	$110.0K	$80.00K
Free Cash Flow	-$236.0K	$670.0K
YoY Change	-109.46%	706.84%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation		usd
	CVV	Payments To Deposits From Purchaser Of Mesoscribe Assets PaymentsToDepositsFromPurchaserOfMesoscribeAssets		usd
	CVV	Payments For Capitalized Patent Costs PaymentsForCapitalizedPatentCosts		usd
	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0000766792
CY2023Q3	CVV	Employee Retention Credit Receivable Noncurrent EmployeeRetentionCreditReceivableNoncurrent		usd
CY2022Q4	CVV	Deposits From Purchaser Of Mesoscribe Assets DepositsFromPurchaserOfMesoscribeAssets		usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2022Q3	us-gaap	Interest Expense InterestExpense		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable		usd
	CVV	Increase Decrease In Employee Retention Credit Receivable IncreaseDecreaseInEmployeeRetentionCreditReceivable		usd
	us-gaap	Loans Assumed1 LoansAssumed1		usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods		usd
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	1-16525
	dei	Entity Registrant Name EntityRegistrantName	CVD EQUIPMENT CORPORATION
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NY
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	11-2621692
	dei	Entity Address Address Line1 EntityAddressAddressLine1	355 South Technology Drive,
	dei	Entity Address City Or Town EntityAddressCityOrTown	Central Islip
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11722
	dei	City Area Code CityAreaCode	631
	dei	Local Phone Number LocalPhoneNumber	981-7081
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	CVV
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6824511	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14285000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14365000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2585000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3788000	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	2895000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	2170000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	4290000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2538000	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	848000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	797000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	24903000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	23658000	usd
CY2022Q4	CVV	Employee Retention Credit Receivable Noncurrent EmployeeRetentionCreditReceivableNoncurrent	1529000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12207000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12596000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	107000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	119000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10000	usd
CY2023Q3	us-gaap	Assets Assets	37227000	usd
CY2022Q4	us-gaap	Assets Assets	37912000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1477000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1454000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1711000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2591000	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	80000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	77000	usd
CY2023Q3	CVV	Deposits From Purchaser Of Mesoscribe Assets DepositsFromPurchaserOfMesoscribeAssets	597000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4858000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4042000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	8723000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8164000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	288000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	349000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	9011000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	8513000	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6820665	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6820665	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6760938	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6760938	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	68000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	67000	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	28434000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	27712000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-286000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1620000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	28216000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	29399000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37227000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37912000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6234000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8119000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19998000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18579000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	4636000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	5699000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	14579000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	13952000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	1598000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	2420000	usd
	us-gaap	Gross Profit GrossProfit	5419000	usd
	us-gaap	Gross Profit GrossProfit	4627000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	704000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	518000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1865000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1397000	usd
CY2023Q3	us-gaap	Selling Expense SellingExpense	434000	usd
CY2022Q3	us-gaap	Selling Expense SellingExpense	290000	usd
	us-gaap	Selling Expense SellingExpense	1281000	usd
	us-gaap	Selling Expense SellingExpense	895000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1450000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1490000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4410000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3937000	usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-162000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	111000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	2588000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	2298000	usd
	us-gaap	Operating Expenses OperatingExpenses	7829000	usd
	us-gaap	Operating Expenses OperatingExpenses	6229000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-990000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	122000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2410000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1602000	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	173000	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	43000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	400000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	74000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	6000	usd
	us-gaap	Interest Expense InterestExpense	18000	usd
	us-gaap	Interest Expense InterestExpense	5000	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-107000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	42000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-250000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	70000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	91000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	11000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	237000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-59000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	515000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-170000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-753000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	63000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1895000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1772000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-753000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	63000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1906000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1773000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6789487	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6736764	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6787415	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6730263	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6789487	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6740692	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6787415	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6730263	shares
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	28719000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	28719000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-753000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	250000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	28216000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	27540000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	63000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	119000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	27722000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	29399000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1906000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	647000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	76000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	28216000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	29187000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	29187000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1773000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	308000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	27722000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	27722000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1906000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1773000	usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-162000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	111000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	647000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	307000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	545000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	538000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1163000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1404000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	725000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	614000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1756000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	909000	usd
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-716000	usd
	CVV	Increase Decrease In Employee Retention Credit Receivable IncreaseDecreaseInEmployeeRetentionCreditReceivable	1529000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	46000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	66000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	113000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	363000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-729000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	687000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	816000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-173000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-76000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2328000	usd
	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	312000	usd
	CVV	Payments To Deposits From Purchaser Of Mesoscribe Assets PaymentsToDepositsFromPurchaserOfMesoscribeAssets	-597000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	308000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	638000	usd
	CVV	Payments For Capitalized Patent Costs PaymentsForCapitalizedPatentCosts	53000	usd
	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment	10000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-23000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-681000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	76000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	57000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1766000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1766000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-80000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4775000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14365000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16651000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14285000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11876000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	11000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1000	usd
	us-gaap	Interest Paid Net InterestPaidNet	18000	usd
	us-gaap	Interest Paid Net InterestPaidNet	8000	usd
	us-gaap	Loans Assumed1 LoansAssumed1	432000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14300000	usd
CY2023Q3	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	usd
	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	usd
CY2022Q3	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	usd
	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	usd
CY2023Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	800000	usd
	CVV	Standard Product Warranty Period From Final Acceptance StandardProductWarrantyPeriodFromFinalAcceptance	P1Y
	CVV	Standard Product Warranty Period From Date Of Shipment StandardProductWarrantyPeriodFromDateOfShipment	P15M
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14300000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14400000	usd
CY2023Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	800000	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	1500000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	36000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	36000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6234000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	8119000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	19998000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	18579000	usd
	CVV	Contract With Customer Cumulative Catchup Adjustment To Revenue Change In Estimate Of Transaction Price And Input Costs ContractWithCustomerCumulativeCatchupAdjustmentToRevenueChangeInEstimateOfTransactionPriceAndInputCosts	15500000	usd
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1100000	usd
	CVV	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod	P12M
CY2023Q3	CVV	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	16762000	usd
CY2023Q3	CVV	Estimated Earnings EstimatedEarnings	11756000	usd
CY2023Q3	CVV	Costs And Estimated Earnings On Uncompleted Contracts CostsAndEstimatedEarningsOnUncompletedContracts	28518000	usd
CY2023Q3	CVV	Billings To Date BillingsToDate	30163000	usd
CY2023Q3	CVV	Net Cost In Excess Of Billings NetCostInExcessOfBillings	-1645000	usd
CY2023Q3	CVV	Deferred Revenues Related To Contracts DeferredRevenuesRelatedToContracts	-318000	usd
CY2023Q3	CVV	Contract Liability In Excess Of Contract Assets ContractLiabilityInExcessOfContractAssets	-1963000	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	2895000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4858000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4000000.0	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1700000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	3700000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1600000	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	2883000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2165000	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	580000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	373000	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	827000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	4290000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2538000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6789487	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6736764	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6787415	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6730263	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3928	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6789487	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6740692	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6787415	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6730263	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	873875	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	349375	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	678000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	290500	shares
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	249000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	119000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	647000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	307000	usd
CY2023Q3	us-gaap	Share Price SharePrice	14.02
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	14.02
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.72	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0339	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	673000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.70
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	254000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	14.02
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	20625	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.18
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	32500	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	6.57
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	873875	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.12
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2023Q3	us-gaap	Assets Assets	37227000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6234000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-990000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-753000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	153000	usd
CY2023Q3	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	83000	usd
CY2022Q3	us-gaap	Assets Assets	33602000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8119000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	122000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	63000	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	136000	usd
CY2022Q3	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	610000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19998000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2410000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1895000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	545000	usd
	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	308000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18579000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1602000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1772000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	538000	usd
	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	1070000	usd

Files In Submission

Name	View Source	Status
cvv-20230930_def.xml	Edgar Link	unprocessable
cvv-20230930_cal.xml	Edgar Link	unprocessable
0001493152-23-041031-index-headers.html	Edgar Link	pending
0001493152-23-041031-index.html	Edgar Link	pending
0001493152-23-041031.txt	Edgar Link	pending
0001493152-23-041031-xbrl.zip	Edgar Link	pending
cvv-20230930.xsd	Edgar Link	pending
ex_31-1.htm	Edgar Link	pending
ex_31-2.htm	Edgar Link	pending
ex_32-1.htm	Edgar Link	pending
ex_32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
cvv-20230930_lab.xml	Edgar Link	unprocessable
cvv-20230930_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CVV
CVD EQUIPMENT CORP Stock $cvv

2023 Q4 Form 10-Q Financial Statement

#000149315223041031 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVV CVD EQUIPMENT CORP Stock $cvv

2023 Q4 Form 10-Q Financial Statement

#000149315223041031 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVV
CVD EQUIPMENT CORP Stock $cvv